Research ArticleDRUG TESTING
Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics
- Christopher W. McAleer1,*,
- Christopher J. Long1,*,
- Daniel Elbrecht1,
- Trevor Sasserath1,
- L. Richard Bridges1,
- John W. Rumsey1,
- Candace Martin2,
- Mark Schnepper2,
- Ying Wang2,
- Franz Schuler3,
- Adrian B. Roth3,
- Christoph Funk3,
- Michael L. Shuler1 and
- James J. Hickman1,2,†
- 1Hesperos Inc., 3259 Progress Drive, Room 158, Orlando, FL 32826, USA.
- 2NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA.
- 3Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
- ↵†Corresponding author. Email: jhickman{at}hesperosinc.com
See allHide authors and affiliations
Science Translational Medicine 19 Jun 2019:
Vol. 11, Issue 497, eaav1386
DOI: 10.1126/scitranslmed.aav1386
